Cost Consequence Analysis Of Darbepoetin Alfa For The Treatment Of Anemia Due To Chronic Kidney Disease (Ckd) In Greece

Conduct an economic evaluation of darbepoetin alfa for the treatment of anaemia due to chronic kidney disease (CKD) compared to other erythropoiesis stimulating agents (ESAs) in patients on haemodialysis (HD) or peritoneal dialysis (PD) in Greece.

Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: G. Kourlaba, I. Boletis, D. Goumenos, C. Iatrou, V. Papagiannopoulou, G. Tritaki, N. Maniadakis Source Type: research